We would like to congratulate Glyconics, which is part of the Deepbridge Life Sciences EIS portfolio for being awarded the internationally recognised ISO 13485:2016 and EN ISO 13485:2016 quality certification for the design and development of their range of diagnostic medical devices.
During the certification process running up to the award, Glyconics participated in an independent audit to demonstrate their robust and consistent quality management system to meet the regulatory requirements of the medical device industry.
Kam Pooni, CEO at Glyconics commented;
"This is a fundamentally important milestone for the business because it is formal recognition that we are developing products which are safe and effective for patients and clinicians. It has been extremely valuable and especially important to our credibility to have that quality assurance independently assessed in such a transparent way."